Form 4: NEO CFO Sherman Reports Equity Transactions

NeoGenomics CFO Jeffrey Scott Sherman reported routine equity transactions, including RSU vesting and tax-related dispositions, as part of his compensation plan.

Summary

• Jeffrey Scott Sherman, Chief Financial Officer of NeoGenomics Inc. (NEO), reported transactions related to his beneficial ownership of company stock.
• On February 21, 2026, Mr. Sherman acquired 42,158 shares of common stock upon the vesting of restricted stock units (RSUs) and disposed of 10,729 shares to satisfy tax withholding obligations.
• On February 23, 2026, he acquired an additional 15,535 shares of common stock from RSU vesting and disposed of 3,783 shares for tax withholding.
• These transactions were made pursuant to a Rule 10b5-1(c) plan.
• Following these reported transactions, Mr. Sherman beneficially owns 220,009 shares of common stock directly.
• He also holds various derivative securities, including 172,242 restricted stock units, 615,998 stock options, and 85,622 performance stock units (at target performance).

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, reflecting routine executive compensation events and the continued accumulation of equity by the CFO, which aligns his interests with shareholders.

Positives

• Acquisition of 42,158 shares of common stock on February 21, 2026, and 15,535 shares on February 23, 2026, through the vesting of restricted stock units, increasing direct beneficial ownership.
• Continued holding of significant derivative securities, including 172,242 restricted stock units, 615,998 stock options, and 85,622 performance stock units, indicating long-term alignment with company performance.
• Inclusion of 434 shares acquired through NeoGenomics' Employee Stock Purchase Plan, demonstrating participation in employee ownership programs.

Negatives

• Disposition of 10,729 shares on February 21, 2026, and 3,783 shares on February 23, 2026, to cover tax withholding obligations related to RSU vesting, which reduces direct beneficial ownership.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that routine insider transaction reports like this Form 4 provide transparency into executive compensation and equity holdings but typically do not offer insights into broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Provides transparency regarding executive compensation and the CFO's equity holdings, aligning management interests with shareholder value through long-term incentive plans.
• Employees: Reflects standard executive compensation practices, which may influence broader employee incentive structures.

Next Steps

• Future vesting of various restricted stock units and performance stock units on their respective anniversary dates.
• Exercise of stock options prior to their expiration dates.

Key Dates

Recommendation

This Form 4 details routine executive compensation events, specifically the vesting of restricted stock units and associated tax withholdings, along with a summary of the CFO's current equity holdings. Such filings are generally not considered price-sensitive as they reflect pre-scheduled compensation activities rather than discretionary trading or new strategic developments. A seasoned investor would likely maintain their current position, as these transactions do not provide new information warranting a change in investment thesis.

Keywords

NeoGenomics, NEO, Jeffrey Scott Sherman, CFO, Form 4, Insider Trading, Restricted Stock Units, Stock Options, Performance Stock Units, Equity Compensation, Tax Withholding, Beneficial Ownership, Rule 10b5-1